GO:0071379 cellular response to prostaglandin stimulus: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0071379 describes any process by which a cell changes its state or activity in response to a prostaglandin stimulus, including movement, secretion, enzyme production and gene expression.
Prostaglandin signaling is initiated by cyclooxygenases (COX-1/COX-2) that convert arachidonic acid to PGH2, which is then isomerized to bioactive prostaglandins such as PGE2, PGF2α, PGI2 and TXA2.
The cellular response to prostaglandins is mediated by G-protein-coupled receptors (EP1-EP4, FP, IP, TP) and downstream second-messenger pathways that alter transcription, secretion and cell behavior.
Prostaglandin responses are central to fever, inflammation, pain, tissue remodeling and skin biology, and are implicated in diseases ranging from arthritis to cancer.
Key experimental models include COX knockout mice, EP receptor knockout mice, and cell-based assays using PGE2 or selective agonists/antagonists.
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models and library screening to dissect prostaglandin response pathways.

Description

The Gene Ontology term GO:0071379, cellular response to prostaglandin stimulus, defines the cellular processes triggered when a cell encounters a prostaglandin. Prostaglandins are lipid mediators derived from arachidonic acid through the sequential action of cyclooxygenases (COX-1 and COX-2) and specific synthases. Once released, they act locally through G-protein-coupled receptors to modulate diverse cellular activities including secretion, enzyme production, gene expression and movement. This term is essential for annotating gene products involved in inflammatory, febrile and homeostatic responses. Researchers studying inflammation, fever, skin biology and aging rely on this ontology term to connect molecular events to organism-level physiology. Understanding the cellular response to prostaglandin stimulus also informs drug discovery targeting COX enzymes and prostaglandin receptors.

cellular response to prostaglandin stimulus At A Glance

GO ID GO:0071379
GO term cellular response to prostaglandin stimulus
Ontology biological_process
Synonym none
Major function Mediates cellular changes (secretion, enzyme production, gene expression, movement) in response to prostaglandins
Definition source QuickGO
Related stimuli Prostaglandin E2 (PGE2), PGF2α, PGI2, TXA2, PGD2
Key upstream enzymes Cyclooxygenase-1 (COX-1), Cyclooxygenase-2 (COX-2)
Key receptors EP1, EP2, EP3, EP4, FP, IP, TP
Representative cell types Keratinocytes, mast cells, fibroblasts, neurons, immune cells

What Is GO:0071379?

According to QuickGO, GO:0071379 (cellular response to prostaglandin stimulus) is any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostaglandin stimulus. In other words, it captures all intracellular signaling and functional changes that occur when a cell detects a prostaglandin molecule in its environment.

Why Is cellular response to prostaglandin stimulus Important in Cell Biology?

GO:0071379 is important because prostaglandin signaling is a fundamental mechanism by which cells respond to inflammation, injury and physiological cues. It underlies fever generation, pain sensitization, tissue remodeling and skin homeostasis. Dysregulation of this response contributes to chronic inflammatory diseases, cancer progression and age-related changes. Understanding the cellular response to prostaglandin stimulus at the molecular level enables the development of targeted therapies that modulate COX enzymes or prostaglandin receptors.
Fever and thermoregulation: prostaglandin E2 acts on preoptic EP3R neurons to switch between fever and torpor.
Inflammation: COX-2-derived prostaglandins are central mediators of inflammatory responses in many tissues.
Skin biology: COX-2 expression is associated with human keratinocyte differentiation, linking prostaglandin responses to epidermal homeostasis.
Cellular aging: prostaglandin production changes with cellular aging, suggesting a role in senescence.
Mast cell biology: human skin mast cells produce and respond to prostaglandins, contributing to allergic and inflammatory reactions.
Airway inflammation: IL-33 enhances mast cell mediator release in human small airways, a process involving prostaglandin responses.
Choroid plexus response: peripheral inflammatory stimuli trigger choroid plexus responses that include prostaglandin signaling.
Gingival fibroblasts: BMP4 micro-immunotherapy reduces PGE2 release in human gingival fibroblasts under inflammatory conditions.
Drug targeting: COX inhibitors (NSAIDs) and EP receptor antagonists are used clinically, highlighting the therapeutic relevance of this pathway.
CRISPR modeling: knockout and knock-in models of COX and prostaglandin receptor genes enable causal dissection of this response.

What Happens During cellular response to prostaglandin stimulus?

Prostaglandin synthesis and release
In simple terms: Cells first make prostaglandins from fats using COX enzymes.
Prostaglandin synthesis begins with arachidonic acid, which is converted by cyclooxygenase-1 (COX-1) or cyclooxygenase-2 (COX-2) to prostaglandin H2 (PGH2). PGH2 is then isomerized by specific synthases to bioactive prostaglandins such as PGE2, PGF2α, PGD2, PGI2 and TXA2. COX-2 is often induced in response to inflammatory stimuli, whereas COX-1 is constitutively expressed in many tissues. In human keratinocytes, COX-2 expression is associated with differentiation, indicating cell-type-specific regulation. Once synthesized, prostaglandins are released into the extracellular space and can act in an autocrine or paracrine manner.
Receptor binding and signal transduction
In simple terms: Prostaglandins bind to specific receptors on the cell surface, triggering signals inside the cell.
Prostaglandins exert their effects by binding to G-protein-coupled receptors: PGE2 acts via EP1, EP2, EP3 and EP4; PGF2α via FP; PGI2 via IP; and TXA2 via TP. These receptors couple to different G proteins (Gs, Gi, Gq), leading to changes in cyclic AMP, calcium and other second messengers. For example, EP3R in preoptic neurons mediates fever and torpor responses. The specific receptor repertoire determines the cellular outcome of prostaglandin stimulation.
Downstream cellular changes
In simple terms: The signal causes the cell to change what it does, such as secreting substances or turning genes on or off.
Activation of prostaglandin receptors leads to diverse cellular responses including secretion, enzyme production, gene expression changes and cell movement. In mast cells, prostaglandin stimulation can enhance mediator release, contributing to allergic responses. In gingival fibroblasts, PGE2 release is modulated under inflammatory conditions. The choroid plexus responds to peripheral inflammatory stimuli with changes that include prostaglandin-dependent signaling. These downstream effects are context-dependent and vary by cell type.
Integration with other signaling pathways
In simple terms: Prostaglandin signals talk to other pathways to fine-tune the cell's response.
Prostaglandin signaling intersects with other inflammatory and homeostatic pathways. For instance, IL-33 enhances mast cell responsiveness and mediator release in human small airways, a process that may involve prostaglandin signaling. BMP4 micro-immunotherapy reduces PGE2 release in human gingival fibroblasts, indicating cross-talk between BMP and prostaglandin pathways. In the choroid plexus, peripheral inflammatory stimuli trigger a coordinated response that includes prostaglandin-mediated events. Such integration ensures that cellular responses are appropriate to the physiological context.
Termination and feedback
In simple terms: The cell shuts down the response when the prostaglandin signal is no longer needed.
Prostaglandin signaling is terminated by degradation of prostaglandins and desensitization of receptors. Enzymes such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH) metabolize prostaglandins, while receptor phosphorylation and internalization reduce sensitivity. Feedback loops also regulate COX-2 expression, which is tightly controlled at transcriptional and post-transcriptional levels. In aging cells, prostaglandin production and response may change, reflecting altered feedback regulation.

Key Genes Involved in GO:0071379 cellular response to prostaglandin stimulus

The following genes and proteins are central to the cellular response to prostaglandin stimulus, based on published literature.
GeneMajor RoleResearch Relevance
PTGS1 (COX-1)Constitutive cyclooxygenase that converts arachidonic acid to PGH2Maintains basal prostaglandin production; target for studying housekeeping responses
PTGS2 (COX-2)Inducible cyclooxygenase that produces PGH2 during inflammationKey drug target; knockout models used to study inflammation and fever
PTGESMicrosomal prostaglandin E synthase, converts PGH2 to PGE2Determines PGE2 levels; relevant to fever and pain
PTGER1 (EP1)PGE2 receptor coupled to Gq/calcium signalingMediates smooth muscle contraction and pain
PTGER2 (EP2)PGE2 receptor coupled to Gs/cyclic AMPInvolved in inflammation and immune regulation
PTGER3 (EP3)PGE2 receptor coupled to Gi; mediates fever and torporTarget for thermoregulation studies; preoptic EP3R neurons
PTGER4 (EP4)PGE2 receptor coupled to Gs; promotes cAMPRoles in bone, inflammation and cancer
PTGFR (FP)PGF2α receptorMediates uterine contraction and ocular pressure
PTGIR (IP)PGI2 receptorVasodilation and platelet inhibition
TBXA2R (TP)TXA2 receptorPlatelet aggregation and vascular tone
HPGD (15-PGDH)Degrades prostaglandinsTerminates signaling; relevant to cancer and aging
PLA2G4A (cPLA2α)Releases arachidonic acid from membranesUpstream of COX; regulates substrate availability
PTGISProstacyclin synthase, converts PGH2 to PGI2Vascular biology and inflammation
TBXAS1Thromboxane synthase, converts PGH2 to TXA2Thrombosis and vascular tone
IL33Cytokine that enhances mast cell mediator releaseModulates prostaglandin-related airway responses
BMP4Growth factor that reduces PGE2 release in gingival fibroblastsCross-talk with prostaglandin pathways
KRT (keratins)Keratinocyte differentiation markersCOX-2 expression associated with differentiation
EP3R neurons (preoptic)Neuronal population mediating fever and torporCentral role in thermoregulation via PGE2

How Is cellular response to prostaglandin stimulus Regulated?

The cellular response to prostaglandin stimulus is regulated at multiple levels. Prostaglandin synthesis is controlled by the expression and activity of COX-1 and COX-2, with COX-2 being highly inducible by inflammatory stimuli. Substrate availability is regulated by phospholipase A2 enzymes that release arachidonic acid. Receptor expression levels and desensitization mechanisms modulate cellular sensitivity to prostaglandins. Degradation by 15-PGDH terminates the signal. Additionally, cross-talk with other pathways, such as BMP4 signaling in gingival fibroblasts, can modulate PGE2 release. In the central nervous system, preoptic EP3R neurons integrate prostaglandin signals to regulate fever and torpor.

cellular response to prostaglandin stimulus and Human Disease

GeneDisease / BiologyPotential Experimental Model
PTGS2 (COX-2)Inflammation, cancer, feverKnockout mice, cell lines with inducible COX-2
PTGER3 (EP3)Fever and torpor regulationPreoptic neuron-specific knockout or knock-in mice
HPGD (15-PGDH)Cancer, agingOverexpression or knockout cell models
IL33Asthma, allergic inflammationMast cell co-culture with airway epithelial cells
BMP4Gingival inflammationHuman gingival fibroblast cultures treated with BMP4
Inflammation and fever
Prostaglandin E2 acts on preoptic EP3R neurons to induce fever, a hallmark of systemic inflammation. COX-2-derived prostaglandins are central to inflammatory pain and swelling, and COX inhibitors are widely used to treat these conditions. Dysregulated prostaglandin signaling contributes to chronic inflammatory diseases such as arthritis and inflammatory bowel disease.
Skin biology and aging
COX-2 expression is associated with human keratinocyte differentiation, linking prostaglandin responses to epidermal homeostasis. Prostaglandin production changes with cellular aging, suggesting a role in age-related skin changes and senescence. Human skin mast cells produce prostaglandins and respond to them, contributing to allergic and inflammatory skin reactions.
Airway and allergic diseases
IL-33 enhances mast cell mediator release in human small airways, a process that involves prostaglandin responses. This pathway is relevant to asthma and allergic inflammation. Prostaglandin D2 and its receptors are also implicated in allergic responses.
Cancer and tissue remodeling
COX-2 is overexpressed in many cancers and promotes tumor progression through prostaglandin-mediated effects on proliferation, angiogenesis and immune evasion. 15-PGDH, which degrades prostaglandins, can act as a tumor suppressor. Prostaglandin signaling also influences tissue remodeling in conditions such as gingival inflammation.

From cellular response to prostaglandin stimulus-Related Genes to Experimental Models

Research QuestionSuitable Model
Does COX-2 drive inflammatory prostaglandin production?PTGS2 knockout cell line or mouse model
How does EP3R mediate fever?Preoptic EP3R neuron-specific knockout or knock-in mice
What is the role of 15-PGDH in prostaglandin degradation?HPGD overexpression or knockout cells
How does IL-33 modulate mast cell prostaglandin release?Human small airway mast cell cultures with IL-33 treatment
Does BMP4 reduce PGE2 in gingival fibroblasts?Human gingival fibroblast cultures with BMP4 micro-immunotherapy
How does COX-2 expression relate to keratinocyte differentiation?Cultured human keratinocytes with differentiation inducers

How to Study the cellular response to prostaglandin stimulus Process

MethodWhat It MeasuresTypical Application
ELISAProstaglandin concentration in supernatantsQuantify PGE2 release from cells
RNA-seqGlobal gene expression changesIdentify transcriptional responses to prostaglandins
CRISPR knockout screenGenes required for prostaglandin responseDiscover novel regulators
Calcium imagingIntracellular calcium fluxMeasure EP1/EP3 receptor activation
cAMP assayCyclic AMP levelsMeasure EP2/EP4 receptor signaling
Western blotProtein expression and phosphorylationAssess COX-2 induction and signaling
Mass spectrometryProstaglandin species profilingComprehensive lipid mediator analysis
ImmunohistochemistryTissue localization of COX enzymesStudy prostaglandin synthesis sites
Measuring prostaglandin production
Prostaglandin levels can be quantified using enzyme-linked immunosorbent assays (ELISA) or mass spectrometry in cell culture supernatants. These methods are used to assess COX activity and the effects of genetic or pharmacological perturbations.
Gene expression analysis
RNA-seq or quantitative PCR can measure expression of COX enzymes, prostaglandin synthases and receptors in response to stimuli. This helps identify transcriptional changes underlying the cellular response to prostaglandin stimulus.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate prostaglandin responses, such as receptors or downstream signaling components. These screens are powerful for discovering novel modulators.
Imaging and functional assays
Calcium imaging, cAMP assays and live-cell imaging can monitor immediate signaling events after prostaglandin stimulation. Functional assays such as secretion or migration measure downstream cellular outcomes.

How CRISPR Can Be Used to Study GO:0071379 cellular response to prostaglandin stimulus

Knockout

CRISPR knockout of PTGS2 (COX-2) or prostaglandin receptors (e.g., PTGER3) can abolish specific arms of the cellular response to prostaglandin stimulus, enabling causal studies. Knockout cell lines are valuable for validating drug targets and dissecting signaling pathways.

Point Mutation

Point mutations can be introduced into prostaglandin receptor genes to mimic naturally occurring variants or to disrupt specific signaling motifs, allowing precise structure-function analysis. For example, mutations in EP3R can test its role in fever.

Knock-in

Knock-in of reporter genes (e.g., fluorescent proteins) into COX-2 or receptor loci enables real-time monitoring of expression and localization in response to prostaglandin stimuli. Tagged knock-in models can also facilitate protein interaction studies.

Overexpression

Overexpression of COX-2 or specific prostaglandin receptors can amplify the cellular response to prostaglandin stimulus, useful for studying downstream effects and for screening inhibitors. Overexpression models also help identify context-dependent signaling.

How EDITGENE Supports cellular response to prostaglandin stimulus Research

Researchers studying cellular response to prostaglandin stimulus-related genes often need to determine whether a candidate gene is causally involved in prostaglandin synthesis, reception or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cellular response to prostaglandin stimulus research.

Frequently Asked Questions About cellular response to prostaglandin stimulus

GO:0071379 is the Gene Ontology term for cellular response to prostaglandin stimulus, describing any cellular change (movement, secretion, enzyme production, gene expression) resulting from a prostaglandin stimulus.
Key genes include PTGS1, PTGS2, PTGES, PTGER1-4, PTGFR, PTGIR, TBXA2R, HPGD, PLA2G4A and others involved in synthesis, reception and degradation of prostaglandins.
Prostaglandins bind to G-protein-coupled receptors (EP1-4, FP, IP, TP), triggering second messenger changes such as cAMP and calcium, which alter cell behavior.
COX-2 is an inducible enzyme that converts arachidonic acid to PGH2, the precursor of all prostaglandins, and is a major regulator of inflammatory prostaglandin production.
PGE2 acts on preoptic EP3R neurons to induce fever and torpor, as shown in recent studies.
Yes, CRISPR knockout, knock-in and overexpression models of COX enzymes and prostaglandin receptors are widely used to dissect these pathways.
Prostaglandin signaling is implicated in inflammation, fever, cancer, skin disorders, allergic airway diseases and aging.
ELISA or mass spectrometry of cell culture supernatants is commonly used to quantify prostaglandin levels.
15-PGDH degrades prostaglandins, terminating the signal, and is relevant to cancer and aging.
Common models include COX knockout mice, EP receptor knockout mice, human keratinocytes, mast cells, gingival fibroblasts and choroid plexus cells.

Conclusion

GO:0071379, cellular response to prostaglandin stimulus, is a fundamental biological process that integrates lipid signaling with cellular behavior. It is essential for understanding inflammation, fever, tissue remodeling and aging, and it offers numerous targets for therapeutic intervention. Advances in CRISPR genome editing enable precise dissection of the genes and pathways involved, from COX enzymes to prostaglandin receptors and downstream effectors. Continued research using these tools will uncover new insights into prostaglandin biology and its role in health and disease.

References

  1. 1. Machado NLS et al.. 2025. Preoptic EP3R neurons constitute a two-way switch for fever and torpor.. Nature 644(8076):463-472 PMID: 40437091
  2. 2. Clària J. 2003. Cyclooxygenase-2 biology.. Curr Pharm Des 9(27):2177-90 PMID: 14529398
  3. 3. Ferrà-Cañellas MDM et al.. 2021. BMP4 micro-immunotherapy increases collagen deposition and reduces PGE2 release in human gingival fibroblasts and increases tissue viability of engineered 3D gingiva under inflammatory conditions.. J Periodontol 92(10):1448-1459 PMID: 33393105
  4. 4. Leong J et al.. 1996. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation.. Exp Cell Res 224(1):79-87 PMID: 8612694
  5. 5. Taylor L et al.. 1981. Prostaglandin production and cellular aging.. Mech Ageing Dev 16(4):311-7 PMID: 6946268
  6. 6. Benyon RC. 1989. The human skin mast cell.. Clin Exp Allergy 19(4):375-87 PMID: 2667702
  7. 7. Belikova M et al.. 2026. IL-33 enhances responsiveness and mast cell mediator release in isolated human small airways.. J Allergy Clin Immunol 157(6):1285-1294.e8 PMID: 41763365
  8. 8. Marques F et al.. 2007. The choroid plexus response to peripheral inflammatory stimulus.. Neuroscience 144(2):424-30 PMID: 17069984
Contact Us
*
*
*
*
How did you hear about us: